Fig. 5
From: Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinoma
a Bar graph representation showing the estimation of hepatic DNA, RNA, and normal serum protein level in seven different experimental groups. b Bar graph representation of the alpha-fetoprotein level in serum of seven different experimental groups. Data are presented as mean ± SE, *P < 0.001 compared with the control group; #P < 0.001 compared with the DEN+CCl4-treated group